Allergy Immunotherapy Market Size, Share, Growth Analysis, By Treatment Type(Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)), By Allergy Type(Allergic Rhinitis, Asthma), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2024-2031

Allergy Immunotherapy Market size was valued at USD 2.4 billion in 2019 and is poised to grow from USD 2.65 billion in 2023 to USD 4.9 billion by 2031, growing at a CAGR of 10.8% in the forecast period (2024-2031).

According to the World Allergy Organization, approximately 10-30% of the global population is currently suffering from different kinds of allergies. Allergy is the body's immune system being overly sensitive to certain substances, such as a particular meal, pollen, fur, or dust. Allergies come in many forms, including those to food, dust, pollen, latex, medications, and others. In order to build antibodies against the allergens, the body is exposed to small amounts of allergies during allergy immunotherapy. Immunotherapy uses regular, low-dose exposure to particular allergens to help the body adjust to their presence, resulting in effective and prompt allergy treatment.

The primary factors propelling the global market for allergy immunotherapy are the expansion of industrialization and population, improvements in healthcare and medicine, and the launch of new immunotherapeutic medications. To increase the market share of the global allergy immunotherapy market, recent regulatory approvals, such as those for oral dissolvable tablets, are further enhanced.

US Allergy Immunotherapy Market is poised to grow at a sustainable CAGR for the next forecast year.